Newsletter | October 15, 2025

10.15.25 -- Better Biopharma: Engineering Bacterial Vector-Based Immunotherapies

SPONSOR

Webinar: Developing your risk-based approach to single-use system integrity

This session explores best practices and evolving regulatory expectations for single-use system (SUS) integrity. Attendees will learn how to apply a holistic, lifecycle-based approach to compliance, define clear user requirements, and build robust contamination control strategies. By the end, participants will be prepared to safeguard efficiency and product quality while meeting regulatory and industry standards. Click here to learn more.

FOCUS ON FILL-FINISH

Forget About Isolators: Switching From Manual Vial To Automated Bag Filling

Discover how transitioning from manual vial filling to single-use bag systems can reduce contamination risk, improve accuracy, and enhance GMP compliance in biopharmaceutical manufacturing.

Can You Simplify Device Decisions And Stand Out From Competition?

Evaluating your system’s performance and compatibility earlier in development can ensure you have a viable product to support development phases.

FILL-FINISH SOLUTIONS

MicroCNX Nano: The Smallest Aseptic Connector On The Market For CGT - CPC

SPONSOR

Join us for November’s Bio-Expo Live, a three-day virtual event designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today!

FOCUS ON DOWNSTREAM MANUFACTURING

Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.

 In this episode of “Better Biopharma,” host Tyler Menichiello is joined by OS Therapies’ CEO, Paul Romness, and chief medical and scientific officer, Robert Petit, Ph.D. The three discuss the development and manufacturing of the company’s lead asset, OST-HER2, a Listeria-based immunotherapy for osteosarcoma.

Considerations For Tangential Flow Filtration Process Development

Optimize your TFF process with single-pass technology by joining experts Mike Dango and Michael Brauchle as they share key strategies for scalable, efficient filtration process development.

Addressing Purification Challenges: Plasma Proteins, Virus Purification

Delve into innovative strategies to surmount purification challenges, including design of experiments (DOE) methodologies and insightful case studies centered around plasma protein and virus purification.

Single-Step Purification Of A 21-mer Oligonucleotide

Explore how the oligonucleotide therapeutics market is advancing with scalable solutions for high-purity purification, supporting global production of life-changing RNA therapies.

DOWNSTREAM MANUFACTURING SOLUTIONS

The Buyer's Guide To Buffer Formulation Equipment - Asahi Kasei Bioprocess

Pharma+ Tubing Retainers - Nordson MEDICAL

Connect With Bioprocess Online: